- €2.10bn
- €2.54bn
- €626.69m
- 91
- 35
- 56
- 66
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 390 | 456 | 501 | 566 | 627 |
Cost of Revenue | |||||
Gross Profit | 340 | 392 | 430 | 485 | 545 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 237 | 292 | 384 | 422 | 460 |
Operating Profit | 153 | 164 | 117 | 144 | 167 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 95.1 | 170 | 85.4 | 117 | 147 |
Provision for Income Taxes | |||||
Net Income After Taxes | 104 | 103 | 50.1 | 67.6 | 114 |
Net Income Before Extraordinary Items | |||||
Net Income | 104 | 103 | 50.1 | 67.6 | 114 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 104 | 103 | 50.1 | 67.6 | 114 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.588 | 0.52 | 0.296 | 0.431 | 0.729 |
Dividends per Share |